Back to UBS Group AG UBS Group AG

HLVXHLVX
14 quarters

Position history for UBS Group AGUBS Group AG's holdings in HILLEVAX INC

As of its Q2 2025 13F, Ubs held 34,324 shares of HLVX (Hillevax), worth $68,305. Ubs' 13F filings listed HLVX from Q2 2022 to Q2 2025, 13 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$6,000

Total Shares Change

-571

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q2
Decreased
34,324
-38.5%
$68,3050.0%—
0
2025-Q1
Increased
55,811
+20.0%
$80,9260.0%—
17
2024-Q4
Increased
46,503
+175.1%
$96,2610.0%—
24
2024-Q3
Increased
16,906
+11.5%
$29,7550.0%—
15
2024-Q2
Decreased
15,168
-47.4%
$219,3300.0%—
0
2024-Q1
Decreased
28,861
-9.6%
$479,9580.0%—
0
2023-Q4
Increased
31,910
+113.2%
$512,1560.0%—
39
2023-Q3
Decreased
14,967
-2.0%
$201,3060.0%—
0
2023-Q2
Increased
15,266
+90.4%
$262,4230.0%—
37
2023-Q1
Increased
8,018
+373.9%
$132,5370.0%—
24
2022-Q4
Increased
1,692
+9300.0%
$28,3070.0%—
21
2022-Q3
Decreased
18
-96.8%
$00.0%—
0
2022-Q2
New
571
-
$6,0000.0%—
24

Other major holders of HLVX: Carlyle Group Inc., FRANKLIN TEMPLETON INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used